Comparison of bamlanivimab with or without etesevimab and casirivimab-imdevimab in clinical outcomes in patients with COVID-19: a systematic review and meta-analysis.

J Chemother

Department of Emergency and Critical Care Medicine, West China School of Public Health, West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.

Published: February 2025

Download full-text PDF

Source
http://dx.doi.org/10.1080/1120009X.2024.2352268DOI Listing

Publication Analysis

Top Keywords

comparison bamlanivimab
4
bamlanivimab etesevimab
4
etesevimab casirivimab-imdevimab
4
casirivimab-imdevimab clinical
4
clinical outcomes
4
outcomes patients
4
patients covid-19
4
covid-19 systematic
4
systematic review
4
review meta-analysis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!